CCM vs. PIII, BNR, XGN, ENZ, TOI, PMD, MRAI, ATIP, BRTX, and KDLY
Should you be buying Concord Medical Services stock or one of its competitors? The main competitors of Concord Medical Services include P3 Health Partners (PIII), Burning Rock Biotech (BNR), Exagen (XGN), Enzo Biochem (ENZ), Oncology Institute (TOI), Psychemedics (PMD), Marpai (MRAI), ATI Physical Therapy (ATIP), BioRestorative Therapies (BRTX), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry.
Concord Medical Services vs.
P3 Health Partners (NASDAQ:PIII) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, valuation and community ranking.
Concord Medical Services has lower revenue, but higher earnings than P3 Health Partners.
P3 Health Partners presently has a consensus price target of $2.38, suggesting a potential upside of 1,052.91%. Given P3 Health Partners' stronger consensus rating and higher probable upside, research analysts plainly believe P3 Health Partners is more favorable than Concord Medical Services.
7.8% of P3 Health Partners shares are owned by institutional investors. 17.9% of P3 Health Partners shares are owned by company insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Concord Medical Services received 193 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 60.99% of users gave Concord Medical Services an outperform vote while only 26.67% of users gave P3 Health Partners an outperform vote.
Concord Medical Services has a net margin of 0.00% compared to P3 Health Partners' net margin of -6.95%. Concord Medical Services' return on equity of 0.00% beat P3 Health Partners' return on equity.
In the previous week, Concord Medical Services had 1 more articles in the media than P3 Health Partners. MarketBeat recorded 1 mentions for Concord Medical Services and 0 mentions for P3 Health Partners. Concord Medical Services' average media sentiment score of -0.11 beat P3 Health Partners' score of -0.75 indicating that Concord Medical Services is being referred to more favorably in the news media.
P3 Health Partners has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, Concord Medical Services has a beta of -0.37, suggesting that its stock price is 137% less volatile than the S&P 500.
Summary
Concord Medical Services beats P3 Health Partners on 9 of the 16 factors compared between the two stocks.
Get Concord Medical Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Concord Medical Services Competitors List
Related Companies and Tools
This page (NYSE:CCM) was last updated on 1/21/2025 by MarketBeat.com Staff
Free CCM Stock Alerts